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Introduction.\p=m-\Duringrecent years, and especially since the intro-
duction of the sodium citrate method, blood transfusion has become one
of the most common forms of treatment of the various types of
primary and secondary anemias. Thus far, however, little is known
as to the length of life of the transfused erythrocytes in patients with
primary and secondary anemia, and until the recent work of Ashby 1
no observations had been made on this subject. This investigator
studied the length of life of transfused red corpuscles in pernicious
anemia and found the average to be about three months. Previous
to this time various observers had claimed the length of life of the
red corpuscles to be from fourteen to fifty-two days.2 Information
on this point seemed desirable in that it might demonstrate the practical
value of transfusion, serve as an aid in deciding what the proper
intervals between transfusions should be, and because of its relation to
the debated problem as to whether or not there is an increase of
hemolysins in the blood serum of individuals with primary and sec-
ondary anemias.
It is generally known that the transfusion of blood is a safe pro¬
cedure when the donor's cells are compatible with the plasma of the
recipient. The fact that the donor's plasma may agglutinate and
hemolyze the cells of the recipient is negligible because the donor's
plasma is. diluted so rapidly as it enters the recipient's blood stream
that agglutination and hemolysis are impossible. It follows then that
Group IV blood (Moss classification) may be transfused without ill
effects into persons whose bloods fall into Groups I, II and III. In
a similar manner a recipient in Group I may be transfused with bloods
of Groups II, III and IV.
From the Medical Service of the Peter Bent Brigham Hospital.
This paper is No. 20 of a series of studies on the physiology and
pathology of the blood from the Harvard Medical School and allied hospitals,
a part of the expense of which has been defrayed from a grant from the
Proctor Fund of the Harvard Medical School for the study of chronic diseases.
1. Ashby: J. Exper. M. 29:267, 1919.
2. Ashby: M. Clin N. America, November, 1919; J. Exper. M. 29:267, 1919.
Ward and Muller; Von Ott; Hunter. W.: Quoted by Ashby, J. Exper. M.
29:207, 1919.
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Technic.—Ashby has devised an ingenious method of following the
life of the transfused red blood cells by means of group agglutina¬
tion.3 Blood is taken from the recipient's finger and mixed with
citrated blood serum which will agglutinate the cells of the recipient
but not the cells which have been transfused. The unagglutinated
cells (i. e., those that have been transfused) may then be counted. The  
technic of the method is as follows (assuming a Group II recipient
and a Group IV donor) : The blood of the recipient is taken in a
leukocyte counting pipet up to the 0.5 mark, and is diluted up to the
11 mark with the agglutinating fluid, which is made up of Group IV
serum and a 4.4 per cent, solution of sodium citrate in the proportion of
1:20. The pipet is shaken and the mixture expelled into a small test
tube in which it is incubated at 37 C. for forty minutes, with thorough
shakings every ten minutes. It is then left in the icebox over night.
Just before counting, the mixture is shaken and a drop placed in the
blood counting chamber and, as directed by Ashby, "160 small squares
in each of the two chambers are counted, the average of the counts
taken and multiplied by 1100/2 to give the number of unagglutinated
or transfused corpuscles per cubic millimeter of blood." Controls on
the activity of the agglutinating serum are made by using the technic
described above on blood of an untransfused individual in Group II.
Theoretically, all the Group II cells should be agglutinated by the Group
IV serum ; practically, however, there remain unagglutinated on an
average of from 20,000 to 50,000 cells per c.mm. Serum which will
agglutinate the blood of a normal person in Group II·, leaving only
50,000 cells per c.mm. unagglutinated may be considered to be active.
When the unagglutinated cell counts in transfused individuals remain
higher than these control counts, it may be assumed that the number
of unagglutinated corpuscles in excess of the control count represent the
number of unagglutinated donor's cells present in the circulation. Cases
have been studied by us according to Ashby's method and technic. All
counts have been made in duplicate, and the figures in the accompanying
tables represent the average. In the cases reported, controls on the
serum were made as described above, and, except in two instances, the
same agglutinating serum was used throughout for all patients. Control
counts of the new and old serums were shown to be practically identical
before the changes were made.
Observations on Patients with Pernicious Anemia.—Four patients
with pernicious anemia, whose bloods were in Group II, were trans¬
fused with citrated blood from donors in Group IV. Counts were
then made of the transfused or unagglutinated cells in the bloods of
these recipients, and repeated many times until the total transfused
cells dropped to the level of the control counts. These patients pre¬
sented the clear cut and classical signs and symptoms of primary
3. Ashby: J. Exper. M. 34:147, 1921.
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anemia, but among them were representatives of the different stages
of the disease. Patient A was in the sixth year of the disease, was
bedridden and had been observed in a remission during his stay in
the hospital the year before, but in a series of counts taken before
his transfusion his erythrocytes were found to be steadily decreasing.
Patient C, in the third year of the disease, was also bedridden and
his red blood cell counts showed the same general curve as the counts
of Patient A. In contrast, Patients  and D were in the earlier stages
of the disease, had been able to do some work and were ambulatory
at the time of their transfusion.
The observations on Patient D are of especial interest in that the
donor for transfusion was another patient with pernicious anemia(Group IV). When the donor was bled, 300 c.c. were withdrawn and
he was immediately transfused with 800 c.c. of normal blood. The
volume of cells in the 300 c.c. of pernicious anemia blood being very
small, the unagglutinated cell count in this recipient never rose above
97,000 per c.mm. Frequent counts were made in this case, and the
control counts which were made on untransfused normals in Group II
and also on the blood of an untransfused patient with pernicious anemia
in Group II, agreed closely.
REPORT OF CASES
Case 1.—Patient A (Medical No. 13211) was a man, aged 41, belonging to
Group II. His symptoms began four years before his entrance to the hospital.
They were weakness, pallor, distress after eating and numbness of the fingers
and toes. Two years previously, while under observation in the hospital, he
had a typical remission with marked improvement of all his symptoms except
the numbness of the extremities. Eight months later he again began to grow
steadily weaker. In the month previous to his present entrance to the hos¬
pital his red cell count dropped from 1,332,000 to 676,000. He was then
transfused with S7S c.c. citrated blood of Group IV. Blood findings before
transfusion were: white cell count. 2,500 per c.mm.; hemoglobin, 30 per cent.;
platelets, 98,000 per c.mm. ; reticulated cells, 0.S per cent. The blood picture
was typical of pernicious anemia (Table 1, Fig. 1).
TABLE 1.—Blood Picture of Patient A
No. of Unagglutinated or
Days Date Bed Blood Cells Donor's Cells
1 Nov. 16,1920. 1,152,000
18 Dec. 3,1920. Transfused 575 c.c. citrated blood, Group IV
18 Dec. , . 1,024,000 530,000
23 Dec. 8,1920. 1,936,000 535,700
28 Dec. 13,192 . 1,800,000 691,900
49 Jan. ,1921. 1,552,000 553,850
59 Jan. 13,192 . 1,216,000 464,200
56 Jan. 20, 1. 848,000 349,800
73 Jan.27,1921. 1,344,000 300,30077 Jan.31,1921. 811,436 148,50078 Feb. 1,1921. 884.268 228,25079 Feb. 2, . Transfused 600 c.c. citrated blood, Group II
85 Feb. 8,1921. 1,160,000 229,90091 Feb.14,1921. 1,160,00095 Feb. 18,1921. 1,088,000
101 Feb.24,1921. 904,000 301,400
106 March 1,1921. 1,328,000 351,450
110 March 4, . 1,744,000 258,500
116 Marchl0,1921. 1,312,000 122,650
120 March 14,1921. 1,094,808 100,650
128 March 22, . 848,000 73,150
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Case 2.—Patient  (Medical No. 15159), a woman aged 46, also belonged
to Group II. Her illness began one year before admission to the hospital.
The symptoms were gradually increasing weakness and pallor, several attacks
of diarrhea and slight numbness of the fingers. She had been able to do a
little work around the house. Her blood report before transfusion was as
follows : Red cell count, 3,456,000 per c.mm. ; reticulated cells, 0.9 per cent. ;
white cell count, 4,700 per c.mm.; platelets, 151,000 per c.mm. The blood smears
showed the typical findings of pernicious anemia. She was transfused with
400 c.c. of citrated blood from a Group IV donor (Table 2, Fig. 2).




Days Date Bed Blood Cells Donor's Cells
1 Jan. 9,1921. 3,456,000
1 Jan. , . Transfused 400 c.c. citrated blood. Group IV3 Jan.11,1921. 4,152,000 464,750
13 Jan.21,1921. 4,648,000 381,150
19 Jan.27,1921. 4,338,000 282,150
24 Feb. 1,1921. 4,256,000 247.500
31 Feb. 8, . 3,592,000 307,450
38 Feb.15,1921. 5,446,000*
51 Feb.28,1921. 5,338,000 259,600
55 March 4,1921..'. 3,688,000 347,600
75 March24,1921. 4,368,000 216,150
90 April 8,1921. 4,214,000 110,000
98 Aprilie,19 . 4,320,000 106,150
111 April 29, 21. 4,556,000 35,200
* The sudden rise in the total red blood cell curve was due to a short remission as shown
by a sudden increase in the number of reticulated red cells just previous to the rise ;n the
total red cell count.
Case 3.—Patient C (Medical No. 14705) was a woman, aged 55, belonging
to Group II. Two years before entrance to the hospital, a gradually increas¬
ing weakness, pallor and gastric distress marked the onset of her illness. Then
she developed numbness of the hands and feet. Her blood findings before
transfusion were: hemoglobin, 45 per cent.; red cell count, 2,356,000 per c.mm.;
reticulated cells, 1.5 per cent.; white cell count, 4,100 per c.mm. The stained
smear was typical of pernicious anemia. She was transfused with 600 c.c.
citrated blood from a Group IV donor and later had several transfusions of
Group II blood (Table 3, Fig. 3).
TABLE 3.—Blood Findings of Patient C
No. of Unagglutinated or
Days Date Red Blood Cells Donor's Cells
1 Jan.18,1921. 1,268,000
1 Jan. 18,1921. Transfused 250 c.c. citrated blood, Group IV
3 Jan.21,1921. 1,028,000 238,150
7 Jan. 25,1921. Transfused 600 c.c. citrated blood, Group II
10 Jan.28,1921. 2,356,000 165,000
14 Feb. 1,1921. 2,016,000 161,700
16 Feb. 3, . Transfused 550 c.c. citrated blood, Group II
17 Feb. 4,1921. 2,776,000 189,750
43 Marchl9,1921. 1,360,000 124,850
43 March19,1921. Transfused 500 c.c. citrated blood, Group  
71 Aprilie, 921. 1,544,000 57,750
Case 4.—Patient D (Medical No. 15642), a man aged 50, belonging to
Group II, noticed symptoms of weakness and pallor three months before admis¬
sion to the hospital. One month later he had a sore tongue, distress after
eating and numbness of the fingers. He had been able to work until shortly
before he entered the hospital. His blood findings at entrance were as fol¬
lows: hemoglobin, 18 per cent.; red cell count, 1,224,000 per c.mm.; reticulated
cells, 0.9 per cent. ; white cell count, 5,600 per c.mm., and platelets, 128,000
per c.mm. The smear was characteristic of pernicious anemia. He was trans¬
fused with 300 c.c. of Group IV blood from another patient who had a typical
pernicious anemia (Table 4, Fig. 4).
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Fig. 1.—Blood findings of Patient A. In this and the accompanying charts
the figures on the left border represent millions in the total red blood cell
counts, and hundreds of thousands in the unagglutinated or transfused red
blood cell counts.
Fig. 2.—Blood findings of Patient B.
Fig. 3.—Blood findings of Patient C.
Fig. 4.—Blood findings of Patient D.
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TABLE 4.—Blood Findings of Patient D
No. of Unagglutinated or
Days Date Red Blood Cells Donor's Cells
1 March19,1921. 1,224,000
1 March 19,1921.Transfused 300 c.c. citrated blood, Group IV (P.   
3 March22,1921. 1,401,000
6 March25,1921. 1,200,000 86,350
9 March28,1921. 1,448,000
10 March29,1921. 1,520,000 89,650
11 March 30,1921. 1,928,000 87,100
12 March31,1921. 1,864,000 86,900
13 April 1,1 . 1,704,000 94,600
14 April 2, 921. 1,648,000 80,850
16 April 4,1 . 1,680,000 78,650
17 April 5,1921. 1,688,000 84,150
18 April 6,1921. 1,568,000 94,050
19 April 7, . 2,144,000 90,200
23 Aprilll,1921. 2,064,000 78,100
25 April 13,1921. 2,120,000 80,850
31 April 19, . 2,560,000 96,800
36 April24,1921. 2,688,000 84,700
40 April 28,1921. 2,804,000
47 May 5.1921. 3,832,000 82,500
68 May 26,192 . 2,600,00* 75,90082 June9,1921. 2,528,000 74,250
109 July 6,1921. 1,600,000 47,850
111 July 8, . 1,872,000 54,833
Observations on Patients with Secondary Anemia.—Four cases(E, F, G and H) of secondary anemia, accompanying an advanced
nephritis, were studied in the same way. Before transfusion, the
patients showed progressive anemias as proved by decreasing red cell
counts. Patients F and H were bleeding constantly from the kidneys
and their urines showed gross blood. Patient E had a very small
amount of blood in the urine, averaging from five to six red blood
corpuscles per low power field when examined microscopically, while
Patient G showed no evidence of hematuria or bleeding elsewhere.
Case 5.—Patient E (Medical No. 15126), a man, aged 32, in Group II, had
had chronic nephritis for about six months before admission to the hospital.
On entry his systolic blood pressure was 190; diastolic, 110. Phenolsulphone¬
phthalein excretion was 42 per cent., blood urea nitrogen, 20 mg. per hundred
c.c. of blood. His urine showed a few red blood cells constantly, averaging
about five or six per low power microscopic field. The blood findings were :
hemoglobin, 60 per cent. ; red cell count, 4,060,000 per c.mm. ; reticulated
cells, 0.9 per cent. ; white cell count, 9,650 per c.mm. The red corpuscles were
practically normal in size and shape but showed definite achromia. He was
transfused with 600 c.c. citrated blood from a Group IV donor (Table 5. Fig. 5).
TABLE 5.—Blood Findings of Patient E
No. of Unagglutinated or
Days Date Bed Blood Cells Donor's Cells
1 Jan. 15,1921. 4,060,000
1 Jan. 15,1921. Transfused 600 ce. citrated blood, Group IV
4 Jan. 18,1921. 4,644,000 623,700
42 March 1,1921. 4,992,000 244,750
52 March11,1921. 4,792,000 332,750
64 March 23, 921. 4,560,000 239,800
70 March 29,1 . 4,656,000 162,250
77 April 5,1921. 4,008,000 143,550
84 Aprill2,1921. 3,544,000 90,750
92 April20,1921. 3,368,000 94,600
99 April27,1921. 3,420,000 82,650
108 May 6,1921. 2,936,000 151,800
119 May17,192 . 3,248,000 34,650
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Case 6.—Patient F (Medical No. 15371), a man, aged 23, in Group II, had
had influenza followed by acute nephritis two years before his entrance to the
hospital. He has passed bloody urine constantly since that time and through¬
out his stay in the hospital the urine showed gross blood. The phenolsul¬
phonephthalein excretion varied from 18 to 35 per cent. ; blood urea nitrogen
was from 26 to 61 mg. per hundred c.c. on a low protein diet. Blood findings
before transfusion were as follows: hemoglobin, 65 per cent.; red cell count,
4,512,000 per c.mm.; reticulated cells, 2 per cent.; white cell count, 11,200 per
c.mm. The smear showed slight achromia of the red cells but was otherwise
essentially normal in appearance. He was transfused with 550 c.c. citrated
blood from a Group IV donor (Table 6; Fig. 6).
TABLE 6.—Blood Findings of Patient F
No. of Unagglutinated orDays Date Bed Blood Cells Donor's Cells
1 March 28,1921. 4,572,0009 April 5,1921. Transfused 550 c.c. citrated blood, Group IV10 April 6,192 . 3,664,000 248,050
 
12 April 8,1921. 3,974,000 275,55015 Aprilll,1921. 4,040,000 259,60017 Aprill3,1921. 4,160,000 298,45023 Aprill9,1921. 4,736,000 294,80030 ApriI26,1921. 3,072,000 208,45036 May 2,1921. 3,216,000 202,95039 May 5,1921.:. 3,552,000 242,00046 ayl2,1921. 3,416,000 189,20053 May19,1921. 3,208,000 143,00056 ay22.1921. 4,288,000 176,55069 June 4,1921. 2,816,000 156,75092 June27,1921. 3,828,000 83,60096 July 1,1921. 3,600,000 68,750
108 July 13, 92 . 3,506,448 42,185
114 July 19,1 1. 4,016,000 33,000
Case 7.—Patient G (Medical No. 14976), a man, aged 33. in Group II, had
had nephritis for about eight months. Physical examination revealed ascites
and considerable edema of the genitals and lower extremities. The blood pres¬
sure was: systolic, 128; diastolic, 96. Phenolsulphonephthalein excretion was
13 per cent., and blood urea nitrogen was 25 mg. per hundred c.c. The urinary
sediment contained many hyalin, granular and waxy casts but no red blood
cells. Before transfusion the red count was 3,736,000 per c.mm. ; reticulated
cells, 0.9 per cent. ; hemoglobin, 45 per cent. The stained smear showed prac¬
tically normal red cells with slight achromia. He was transfused with 250 c.c.
citrated blood (containing 10 000,000 red corpuscles per c.mm.) from a donor
in Group IV (Table 7, Fig. 7).




Days Date Bed Blood Cells Donor's Cells
1 March28,1921. 3,764,00035 May 2,1921. 2,896,000
45 May 22,192 . 3,736,000 45,65057 May24,1921. Transfused 250 c.c. citrated blood, Group IV59 May 26,1921. 5,064,000 253,00067 June 3,1921. 4,576,000 261,25074 Junel0,1921. 3,984,000 399.85079 Junel5,1921. 4,688,000 280,50085 June 21, 921. 5,024,000 265,65094 June 30, . 4,416.000 163,350105 July 11,1921. 4,344,000 179,30t
112 July 18,1921. 3,712,000 130,550142 August 17,1921. 4,456,000 69,300150 August 25, . 4,128.000 66,100156 August 31, 921. 4,f00,000 49,550
Downloaded From: http://archinte.jamanetwork.com/ by a University of Calgary User  on 05/27/2015
IO 20 3 0 fO S3 60 70 90 100 110 120
Fig. 5.—Blood findings of Patient E.
Fig. 6.—Blood findings of Patient F.
Fig. 7.—Blood findings of Patient G.
Fig. 8.—Blood findings of Patient H.
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Case 8.—Patient H (Medical No. 15653), a boy, aged 16, in Group II had
nephritis, of two months' duration, which followed a respiratory infection. He
was not edematous and his blood pressure was: systolic, 148; diastolic, 90. The
urinary sediment contained hyalin and finely granular brown casts and many
red blood cells so that the blood was visible grossly from time to time. Phenol¬
sulphonephthalein excretion was 50 per cent., and the blood urea nitrogen was
12 mg. per hundred c.c. His red cell count before transfusion was 3,360,000
per c.mm. ; reticulated cells, 2.2 per cent. ; hemoglobin, 52 per cent. ; white cell
count, 6,900 per c.mm. The stained smear showed slight achromia of the red
corpuscles. He was transfused with 250 c.c. citrated blood (containing
10,000,000 red corpuscles per c.mm.) from a Group IV donor (Table 8, Fig. 8).
TABLE 8.—Blood Findings of Patient H
No. of
. Unagglutinated or
Days Date Bed Blood Cells Donor's Cells
1 Aprill6,1921. 4,144,00017 May 2,1921..-.. 3,672,00037 ay22,1921. 3,360,000
39 May24,1921. Transfused 250 c.c. citrated blood. Group IV
41 ay26,1921. 4,497,000 451.550
49 June 3,1921. 4,560,000 281,150
56 Junel0,1921. 4,344,000 306,350
61 June 15,1921. 4,408,000 238,150
66 June20,1921..·. 4,456,000 226,05075 June29,1921. 5,000,000 162,250
87 July 11, 921. 5,256,000 141,350
94 July 18,1921. 4,904,000 123,750
103 July 27,1921. 5,144,000 88,000
111 August 4,1921. 5,344,000 79,750
119 August 12,192 . 4,952,000 62,700
124 August17,1921. 5,616,000 68,200
150 Auguse 25,1921. 4,592,000 58,850
156 August 31, . 5,208,000 78.100
164 Sept.8,1921. 4,688,000 48,950
DISCUSSION
Unfortunately it has not been possible in this investigation to study
the length of life of cells transfused into normal individuals, but, in
the light of the present findings, further studies on normals should be
made. Ashby observed only one normal case until the transfused
corpuscles disappeared from the circulation and found that they lived
for thirty-nine days, while in her other two cases, which were followed
incompletely, the cells lived about thirty-two days. In a later study,
this author reports the length of life of transfused red blood cells in
eight patients "without blood disease" to be very variable, some living
as long as one hundred days, others disappearing in thirty days. The
protocols of these patients, however, show that some of them had cancer
or other malignant growths, one was in the tertiary stage of syphilis
and none can be regarded as normal. Indeed, one finds included in the
list patients with some of the most common and frequent causes of
secondary anemia, and while in the technical sense of the term they
may be "without blood disease" they show a decided disturbance of the
blood.
Ashby found the length of life of the transfused erythrocytes in
pernicious anemia to be about three months and concluded that there
was no hemolytic toxin producing the anemia in this disease. The
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results of this investigation show the length of life of the transfused
corpuscles in primary anemia, and in the one type of secondary anemia
studied, to be from seventy-one to one hundred and ten days, but it is
felt that no conclusion regarding the presence of a hemolysin is justi¬
fiable, because these observations furnish no direct evidence on this
point, and also because of the lack of accurate information as to the
duration of life of red corpuscles transfused into normal persons.
Furthermore, no evidence could be found to support the claim, made
by Ashby, that "on the whole, blood destruction is quiescent in per¬
nicious anemia." The results here show merely that the length of life
of transfused erythrocytes is greater in patients with primary anemia
and with secondary anemia due to nephritis,· than in the one normal
case on record ; and this is only known to be true when the donor and
recipient are of unlike groups. Whether or not the same would hold
true when the donor and the recipient are in the same group it is not
possible to say. In addition, these observations do not throw any
light on what is happening to the patient's own cells during this period,
and there is no reason to believe that the rate of destruction of the
transfused cells is any indication of the rate of destruction of the
patient's own cells, for it is possible that the transfused erythrocytes,
belonging to a group foreign to the patient, are not acted on in the
same manner as the patient's own cells.
It has not been proved conclusively that the transfused blood cells
function during their stay in the circulation, but the fact that many
of the patients show some clinical improvement after transfusion sug-
gets that this is the case. Moreover, the observations of several investi¬
gators have shown that any foreign material, such as manganese or
carbon particles and foreign blood cells, when injected into the blood
stream of an animal are removed quickly.4 This being the case, if the
transfused cells were not living and functioning as normal red blood
corpuscles one would expect them to be removed from the blood
stream.
Several rises in the counts of transfused red cells were noted just
before their final disappearance (Figs. 1 and 5). As the control counts
on these days did not increase, and there was no variation in technic,
differential counts of the number of microcytes were made to see if a
breaking up or fragmentation of cells might account for these rises,
but no evidence to support this theory was found. In view of the
coincident rise of the total red blood cell count, it is not unlikely that
changes in the blood volume account for the rise. One other possible
explanation of this occurrence is that following transfusion there may
be a definite improvement in the circulation with a resulting rise in
4. McJunkin: J. Exper. M. 21:59, 1918. Lund, Shaw and Drinker: J. Exper.
M. 33:231, 1921. Drinker and Shaw: J. Exper. M. 33:77, 1921.
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the number of circulating cells in the periphery. This seems plausible
in Case. 1.
The most striking result of these observations on the life of the
transfused cells in the primary and secondary anemias is their sur¬
prisingly long stay in the circulation of the recipient. The longest
period before the disappearance of the last cells was 113 days and the
shortest fifty-nine days, the average for all these observed being about
eighty-three days. It must be remembered that in addition to this
period of life as transfused erythrocytes in a foreign circulation, that
some of these corpuscles were functioning as adult cells in the donor
before they were transferred, but of the length of time that they had
been in the adult stage nothing is known, nor is there any accurate
knowledge of the period of time required for a red blood cell to pass
from its immature nucleated stage to its adult nonnucleated stage.
These considerations, together with the findings of this investigation,
indicate that the life of the human red blood cell is much longer than
has been believed to be the case. Whether the duration of life and
the stages of development of these cells would have been the same
in the circulation of the individual from whom they originally came it
is not possible to say.
It is also of interest that the life of the transfused red cells in
both secondary and primary anemias was of the same duration. It
seems almost probable that the transfused cells are adult red corpuscles
of varying ages, and this, if true, would account for their steady
gradual disappearance from the circulation of the recipient, also for
the fact that some of the cells begin to disappear almost immediately
after transfusion. This explanation is also compatible with the idea
that new red corpuscles are being constantly supplied to the circulation.
There were no sudden drops in the transfused cell count during these
observations, but this may be due to the time intervals between counts,
and in this connection it will be noted that two of the patients with
pernicious anemia were women, both of whom had ceased to men¬
struate, so that no loss of transfused cells can be accounted for by
that route, as noted by Ashby. In Case 6, in which there was con¬
stantly a large amount of blood in the urine, an attempt was made to
determine the number of transfused corpuscles that were being lost in
this way, but this was unsuccessful as the total unagglutinated count
of the red corpuscles in the urine after centrifugalization was less than
the control counts of the agglutinating serum on normal Group II
blood.
Another point that is clearly brought out in this study is that due
to the long life of the transfused red cells one may expect to tide
patients over the acute stages of primary and secondary anemias by
purely mechanical means. The improvement after some transfusions,
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except when a real remission begins, might be explained by the increase
in oxygen carriers. This improvement, which is generally of about
two or three months' duration, is probably governed by the fact that
some of the transfused corpuscles seem to function between sixty and
ninety days.
CONCLUSIONS
Red blood corpuscles from donors in Group IV transfused into
patients in Group II with pernicious anemia and anemia secondary to
nephritis, remained in the circulation longer than has been generally
believed to be the case. The last of the transfused red blood cells
disappeared from the circulation in from fifty-nine to 113 days, with
an average of eighty-three days.
No difference was noted in a series of observations in the duration
of the stay of the transtused red blood corpuscles in the circulation
between patients with primary anemia and secondary anemia (due to
nephritis).
In a single observation red blood corpuscles from a patient with
pernicious anemia transfused into another patient with pernicious
anemia, behaved as did the corpuscles from normal donors.
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